BR9509902A - Monoclonal antibody fragments showing immunosuppressive activity - Google Patents

Monoclonal antibody fragments showing immunosuppressive activity

Info

Publication number
BR9509902A
BR9509902A BR9509902A BR9509902A BR9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A
Authority
BR
Brazil
Prior art keywords
monoclonal antibody
antibody fragments
immunosuppressive activity
fragments showing
showing immunosuppressive
Prior art date
Application number
BR9509902A
Other languages
Portuguese (pt)
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9509902A publication Critical patent/BR9509902A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9509902A 1994-12-07 1995-11-25 Monoclonal antibody fragments showing immunosuppressive activity BR9509902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (1)

Publication Number Publication Date
BR9509902A true BR9509902A (en) 1997-10-21

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509902A BR9509902A (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments showing immunosuppressive activity

Country Status (19)

Country Link
EP (1) EP0787151A1 (en)
JP (1) JP2001506122A (en)
CN (1) CN1168679A (en)
AR (1) AR002005A1 (en)
AU (1) AU4256096A (en)
BR (1) BR9509902A (en)
CA (1) CA2206471A1 (en)
CO (1) CO4480041A1 (en)
CZ (1) CZ172497A3 (en)
FI (1) FI972430A (en)
HU (1) HUT77342A (en)
IL (1) IL116228A0 (en)
MA (1) MA23739A1 (en)
NO (1) NO972522L (en)
PE (1) PE52996A1 (en)
PL (1) PL320610A1 (en)
TR (1) TR199501542A2 (en)
WO (1) WO1996017874A1 (en)
ZA (1) ZA9510195B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
WO2000012560A1 (en) * 1998-08-28 2000-03-09 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
DE60035337T2 (en) * 2000-05-12 2008-02-28 Gpc Biotech Ag Human peptides / proteins that cause or cause the killing of cells, including lymphoid tumor cells
US20030086929A1 (en) 2001-10-11 2003-05-08 Tso J. Yun Treatment of prostate cancer by inhibitors of ATP synthase
WO2003033538A1 (en) 2001-10-15 2003-04-24 Kirin Beer Kabushiki Kaisha Anti-hla-dr antibody
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2011123428A1 (en) * 2010-04-01 2011-10-06 Immunomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (en) * 2021-07-22 2024-03-14 서울대학교산학협력단 Anti-HLA-DP monoclonal antibody and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
DE69028713T3 (en) * 1989-12-27 2004-05-13 Centocor, Inc. CHIMERAL IMMUNOGLOBULINE FOR CD4 RECEPTORS
NZ243706A (en) * 1991-07-25 1994-08-26 Idec Pharma Corp Recombinant monkey antibodies, pharmaceutical compositions

Also Published As

Publication number Publication date
AR002005A1 (en) 1998-01-07
AU4256096A (en) 1996-06-26
NO972522L (en) 1997-08-06
CO4480041A1 (en) 1997-07-09
FI972430A0 (en) 1997-06-06
ZA9510195B (en) 1996-06-07
PL320610A1 (en) 1997-10-13
EP0787151A1 (en) 1997-08-06
CN1168679A (en) 1997-12-24
NO972522D0 (en) 1997-06-03
FI972430A (en) 1997-06-06
CZ172497A3 (en) 1997-10-15
PE52996A1 (en) 1996-12-12
MA23739A1 (en) 1996-07-01
HUT77342A (en) 1998-03-30
JP2001506122A (en) 2001-05-15
TR199501542A2 (en) 1996-07-21
IL116228A0 (en) 1996-03-31
CA2206471A1 (en) 1996-06-13
MX9704225A (en) 1997-09-30
WO1996017874A1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
DK1516629T3 (en) Humanized anti-CD-11a antibodies
PT719859E (en) ANTI-ALPHA MONOCLONAL ANTIBODY V-INTEGRINA
IL128406A0 (en) Monoclonal antibodies
DK145493D0 (en) ANTIBODY
EP0870826A4 (en) Novel protein and monoclonal antibody specific thereto
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
DE69738312D1 (en) HEPATITIS B MONOCLONAL ANTIBODIES
BR9509902A (en) Monoclonal antibody fragments showing immunosuppressive activity
EP0977590A4 (en) Human monoclonal antibodies
GB9718911D0 (en) Monoclonal antibodies
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
DE69023717D1 (en) Monoclonal antibody.
DE69427850D1 (en) MONOCLONAL ANTIBODY AGAINST MUCOGLYCOPROTEIN
BR9709080A (en) Human anti-MP52 monoclonal antibody
GB9615027D0 (en) Monoclonal antibodies
DE69324928T2 (en) MONOCLONAL ANTIBODY
DE29512719U1 (en) Monoclonal antibodies against human interleukin-10
SI0742795T1 (en) Immuno-stimulatory monoclonal antibodies
BR1100555B1 (en) humanized monoclonal antibodies.
ZA954678B (en) Monoclonal antibody against cd44v6
BR1100504A (en) anti-ige antibodies.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law